FDA Investigator

Linda L Ng

Latest inspection on record: Grand Prairie, United States, June 2015 · records back to 2013

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 7 inspections across 7 sites are on record.
  • 10 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2015-06-04.

At a glance

Inspections

7

Sites

7

Observations

10

Career since

Apr 2013

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Neos Therapeutics, LP4 Jun 2015Human DrugsView 483 →
Otsuka Pharmaceutical Co., Ltd.5 Dec 2014Human DrugsOn file
Alliance Medical Products, Inc.25 Jul 2014Human Drugs
FRESENIUS KABI IPSUM S.R.L.27 Sep 2013Human DrugsOn file
Gerard Laboratories (Ireland) Ltd.19 Sep 2013Human DrugsOn file

Sites inspected

Neos Therapeutics, LPGrand Prairie, United States1 insp.
Otsuka Pharmaceutical Co., Ltd.Kanzaki-Gun, Japan1 insp.
Alliance Medical Products, Inc.Irvine, United States1 insp.
FRESENIUS KABI IPSUM S.R.L.Villadose, Italy1 insp.
Gerard Laboratories (Ireland) Ltd.Dublin 13, Ireland1 insp.

Co-investigators

Investigators who share inspections with this person.

Linda Thai1 shared
Xiaobin Shen1 shared
Richard L Rutherford1 shared

Full investigator report

Get the verbatim findings behind Linda L Ng's 10 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site